UPDATED May 20, 2024
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
LLY | US$783.18 | 1.7% | 80.5% | US$693.3b | US$850.41 | PE114.9x | E27.3% | 0.7% | ||
MRNA | US$141.01 | 6.1% | 11.3% | US$50.9b | US$138.51 | PS10.5x | E68.8% | n/a | ||
AMGN | US$314.54 | 0.7% | 40.4% | US$167.6b | US$316.06 | PE44.8x | E17.9% | 2.9% | ||
GRPH | US$22.26 | 580.7% | 861.6% | US$190.4m | n/a | PB7.1x | E36.4% | n/a | ||
DHR | US$267.11 | 0.5% | 15.5% | US$196.9b | US$272.68 | PE48.6x | E13.5% | 0.4% | ||
DYN | US$35.38 | 27.8% | 154.0% | US$2.4b | US$42.80 | PB6.5x | E23.8% | n/a | ||
TEVA | US$16.81 | 3.2% | 111.4% | US$18.5b | US$17.34 | PS1.2x | E40.4% | 0% | ||
PTCT | US$40.12 | 21.2% | -32.1% | US$2.5b | US$33.00 | PS3.3x | E55.1% | n/a | ||
REGN | US$987.27 | 0.5% | 31.4% | US$106.0b | US$1,041.93 | PE27.6x | E12.5% | n/a | ||
BNTX | US$92.47 | 2.1% | -14.0% | US$21.9b | US$113.68 | PE181.8x | E7.3% | n/a | ||
ICLR | US$318.72 | 1.3% | 47.6% | US$26.0b | US$354.14 | PE38.6x | E14.1% | n/a | ||
MDGL | US$232.10 | 5.5% | -18.7% | US$4.7b | US$363.86 | PB5.8x | E64.3% | n/a | ||
NVAX | US$14.79 | 13.7% | 96.2% | US$1.8b | US$19.75 | PS2.1x | E71.5% | n/a | ||
APLS | US$43.22 | 4.6% | -50.6% | US$5.0b | US$80.06 | PS10x | E60.2% | n/a | ||
GILD | US$67.90 | 0.3% | -13.6% | US$84.4b | US$82.93 | PE174.4x | E36.5% | 4.5% | ||
RVTY | US$112.02 | 1.6% | -6.8% | US$13.6b | US$123.67 | PE75.4x | E26.4% | 0.3% | ||
IONS | US$38.72 | 3.8% | -4.9% | US$5.4b | US$57.95 | PS7.3x | E36.2% | n/a | ||
BRKR | US$76.47 | 1.9% | 1.8% | US$10.9b | US$83.90 | PE27.7x | E3.6% | 0.3% | ||
BHVN | US$39.32 | 5.2% | 146.7% | US$3.3b | US$57.44 | PB11.5x | E13.5% | n/a | ||
VRTX | US$445.87 | 0.1% | 31.1% | US$114.9b | US$462.55 | PE28.6x | E10.1% | n/a | ||
BGNE | US$174.32 | 0.9% | -28.0% | US$18.1b | US$267.01 | PS6.6x | E60.6% | n/a | ||
ZTS | US$174.39 | 0.2% | -2.9% | US$79.4b | US$211.20 | PE33.3x | E8.6% | 1.0% | ||
PCVX | US$75.93 | 1.8% | 53.5% | US$8.1b | US$103.14 | PB4.2x | E1.3% | n/a | ||
BIIB | US$231.58 | 0.4% | -24.5% | US$33.6b | US$285.92 | PE28.9x | E17.8% | n/a |